Centro de Imagem Diagnosticos SA
BOVESPA:AALR3

Watchlist Manager
Centro de Imagem Diagnosticos SA Logo
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
Watchlist
Price: 14.85 BRL 1.16% Market Closed
Market Cap: 1.8B BRL
Have any thoughts about
Centro de Imagem Diagnosticos SA?
Write Note
Section:
 

Profitability Summary

Centro de Imagem Diagnosticos SA's profitability score is 35/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score
35/100
Profitability
Score
High Profitability Stocks
Health Care Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Centro de Imagem Diagnosticos SA

Revenue
1.2B BRL
Cost of Revenue
-834.7m BRL
Gross Profit
354.3m BRL
Operating Expenses
-316.4m BRL
Operating Income
37.9m BRL
Other Expenses
-256.3m BRL
Net Income
-218.4m BRL

Margins Comparison
Centro de Imagem Diagnosticos SA Competitors

Country Company Market Cap Gross
Margin 		Operating
Margin 		Net
Margin
BR
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
1.8B BRL
30%
3%
-18%
US
Cigna Group
XMUN:CGN
89.7B EUR
11%
4%
1%
US
Cigna Corp
NYSE:CI
92.8B USD
11%
4%
1%
US
CVS Health Corp
NYSE:CVS
68.3B USD
14%
3%
1%
DE
Fresenius Medical Care AG
XMUN:FME
23.5B EUR
25%
7%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.6B USD
28%
9%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.5B EUR
23%
6%
-5%
US
Quest Diagnostics Inc
NYSE:DGX
18B USD
33%
14%
9%
US
DaVita Inc
NYSE:DVA
13B USD
33%
15%
7%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.7B EUR
25%
7%
3%
US
Chemed Corp
NYSE:CHE
8.5B USD
36%
17%
13%
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
Country BR
Market Cap 1.8B BRL
Gross Margin
30%
Operating Margin
3%
Net Margin
-18%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 89.7B EUR
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
Cigna Corp
NYSE:CI
Country US
Market Cap 92.8B USD
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 68.3B USD
Gross Margin
14%
Operating Margin
3%
Net Margin
1%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 23.5B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 20.6B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
3%
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 18.5B EUR
Gross Margin
23%
Operating Margin
6%
Net Margin
-5%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 18B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
DaVita Inc
NYSE:DVA
Country US
Market Cap 13B USD
Gross Margin
33%
Operating Margin
15%
Net Margin
7%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 11.7B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Chemed Corp
NYSE:CHE
Country US
Market Cap 8.5B USD
Gross Margin
36%
Operating Margin
17%
Net Margin
13%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Centro de Imagem Diagnosticos SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
BR
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
1.8B BRL
-22%
-8%
2%
2%
US
Cigna Group
XMUN:CGN
89.7B EUR
7%
2%
10%
7%
US
Cigna Corp
NYSE:CI
92.8B USD
7%
2%
10%
7%
US
CVS Health Corp
NYSE:CVS
68.3B USD
7%
2%
7%
4%
DE
Fresenius Medical Care AG
XMUN:FME
23.5B EUR
4%
2%
5%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.6B USD
5%
2%
8%
5%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.5B EUR
-6%
-2%
3%
1%
US
Quest Diagnostics Inc
NYSE:DGX
18B USD
13%
6%
10%
8%
US
DaVita Inc
NYSE:DVA
13B USD
104%
5%
13%
10%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.7B EUR
4%
2%
5%
3%
US
Chemed Corp
NYSE:CHE
8.5B USD
27%
18%
29%
22%
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
Country BR
Market Cap 1.8B BRL
ROE
-22%
ROA
-8%
ROCE
2%
ROIC
2%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 89.7B EUR
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
Cigna Corp
NYSE:CI
Country US
Market Cap 92.8B USD
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 68.3B USD
ROE
7%
ROA
2%
ROCE
7%
ROIC
4%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 23.5B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 20.6B USD
ROE
5%
ROA
2%
ROCE
8%
ROIC
5%
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 18.5B EUR
ROE
-6%
ROA
-2%
ROCE
3%
ROIC
1%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 18B USD
ROE
13%
ROA
6%
ROCE
10%
ROIC
8%
DaVita Inc
NYSE:DVA
Country US
Market Cap 13B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
10%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 11.7B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Chemed Corp
NYSE:CHE
Country US
Market Cap 8.5B USD
ROE
27%
ROA
18%
ROCE
29%
ROIC
22%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Summary
AALR3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
AALR3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AALR3 stock valuation using valuation multiples.
Wall Street Estimates
AALR3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AALR3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 198,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.